<DOC>
	<DOCNO>NCT00760019</DOCNO>
	<brief_summary>The purpose study determine whether reduce inflammation blood vessel aspirin-like drug call salsalate improve blood vessel function .</brief_summary>
	<brief_title>Inflammation Vascular Function Atherosclerosis</brief_title>
	<detailed_description>To test hypothesis inhibition I [ kappa ] B kinase [ beta ] ( IĸKβ ) , inflammatory mediator , high dose salsalate , restore insulin-mediated endothelium-dependent vasodilation subject atherosclerosis .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Salicylsalicylic acid</mesh_term>
	<mesh_term>Sodium Salicylate</mesh_term>
	<criteria>Nonsmoking adult subject know atherosclerosis Uncontrolled hypertension ( &gt; 140/90 mmHg ) Untreated hypercholesterolemia ( LDL &gt; 160 mg/dL ) Diabetes mellitus Alanine Aminotransferase &gt; 150 Creatinine &gt; 1.4 mg/dL Concommitant use warfarin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>vascular inflammation</keyword>
	<keyword>endothelium-dependent flow-mediated blood vessel function</keyword>
</DOC>